Coptisine是一种从大黄(Chelidonium majus L.)草本植物中分离和纯化的原小檗碱异喹啉生物碱,能够通过逆转吲哚胺2,3-二氧基酶(IDO)活性增强的作用,提高细胞的活力。
HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Coptisine is a protoberberine isoquinoline alkaloid isolated and purified from the herbs of Chelidonium majus L., which can increases cell viability based on its reversal effect on the enhanced activity of Indoleamine 2,3-dioxygenase . |
| Concentration | Treated Time | Description | References | |
| NCI-H1299 cells | 10 μM or 20 μM | 24 h | COP significantly reduced the expression of ATF4 induced by glutamine restriction, leading to substantial inhibition of cancer cell proliferation. | Adv Sci (Weinh). 2024 Sep;11(35):e2401748 |
| NCI-H460 cells | 10 μM or 20 μM | 24 h | COP significantly reduced the expression of ATF4 induced by glutamine restriction, leading to substantial inhibition of cancer cell proliferation. | Adv Sci (Weinh). 2024 Sep;11(35):e2401748 |
| Helicobacter pylori clinical isolates | 25-50 μg/mL | 3 days | To evaluate the antibacterial activity of Coptisine against clinical isolates, results showed that the MICs of Coptisine against clinical isolates were either 25 or 50 μg/mL | J Enzyme Inhib Med Chem. 2018 Dec;33(1):1362-1375 |
| Helicobacter pylori standard strain NCTC 11637 | 25 μg/mL | 3 days | To evaluate the antibacterial activity of Coptisine against H. pylori, results showed that the MIC of Coptisine against NCTC 11637 strain was 25 μg/mL | J Enzyme Inhib Med Chem. 2018 Dec;33(1):1362-1375 |
| Hep3B cells | 50 µM | 24 h | Coptisine markedly increased DNA damage and apoptotic cell death, which was associated with induction of death receptor proteins. Coptisine also significantly upregulated expression of proapoptotic Bax protein, downregulated expression of anti-apoptotic Bcl-2 protein, and activated caspase-3, -8, and -9. In addition, coptisine remarkably increased the generation of reactive oxygen species (ROS), loss of mitochondrial membrane potential (MMP), and release of cytochrome c into the cytoplasm. | Int J Mol Sci. 2020 Jul 31;21(15):5502 |
| MOLM-13 cells | 0–20 μM | 12 h | To evaluate the inhibitory activity of Coptisine on METTL3 and its effect on m6A modification levels. Results showed that Coptisine dose-dependently decreased m6A levels of mRNAs. | Adv Sci (Weinh). 2024 Jul;11(26):e2308786 |
| BEAS-2B | 10 μM | 24 h | no significant effect on KRAS mRNA levels | Nat Commun. 2022 Oct 12;13(1):6016 |
| A549 | 10 μM | 24 h | significantly lowered KRAS mRNA levels | Nat Commun. 2022 Oct 12;13(1):6016 |
| H460 | 10 μM | 24 h | significantly lowered KRAS mRNA levels | Nat Commun. 2022 Oct 12;13(1):6016 |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c nude mice | H460 xenograft tumor model | Intraperitoneal injection | 100 mg/kg | Every other day for two weeks | COP significantly enhanced the inhibitory effect of glutamine-restrictive therapy on tumor growth and effectively disrupted the GCN2-ATF4-ASCT2 axis. | Adv Sci (Weinh). 2024 Sep;11(35):e2401748 |
| Mice | Periodontitis models | Local injection | 20 μM | Daily, until the experimental endpoint | To evaluate the therapeutic effect of Coptisine on periodontitis. Results showed that Coptisine significantly alleviated inflammatory periodontal bone loss and reduced the expression of IL-1β and GSDMD. | Adv Sci (Weinh). 2024 Jul;11(26):e2308786 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
3.12mL 0.62mL 0.31mL |
15.61mL 3.12mL 1.56mL |
31.22mL 6.24mL 3.12mL |
|
| CAS号 | 3486-66-6 |
| 分子式 | C19H14NO4 |
| 分子量 | 320.32 |
| SMILES Code | C12=CC3=CC=C4C(OCO4)=C3C=[N+]1CCC5=C2C=C(OCO6)C6=C5 |
| MDL No. | MFCD03792689 |
| 别名 | Coptisin |
| 运输 | 蓝冰 |
| InChI Key | XYHOBCMEDLZUMP-UHFFFAOYSA-N |
| Pubchem ID | 72322 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, store in freezer, under -20°C |
沪公网安备 31011702889066号
沪ICP备2024050318号-1